Friday 24 February 2023

Nutritional Supplements Market Worth $620.8 Billion By 2030

 The global Nutritional Supplements Market size is expected to reach USD 620.8 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 6.3% from 2022 to 2030. The awareness regarding health and fitness has been on an upward trend in the past few years. During the pandemic, this gained a lot of momentum and has resulted in the massive growth of the market. The increase in the prevalence of chronic diseases and non-communicable diseases has also fueled the growth of the market. Immunity-boosting supplements and food were in high demand across the globe. According to Nutrition Business Journal, there was a massive surge in the purchase of immune supplements, 17 out of 20 vitamin products were immunity-related.

The awareness pertaining to health and fitness has also risen in recent years. With this newfound interest in fitness and well-being, numerous products in the market catering to the needs of fitness enthusiasts and professional athletes have seen a big jump in their demand. A growing number of fitness clubs and gyms all over the globe, an increase in the consumption of products like protein supplements, and high demand for energy-boosting supplements are boosting the growth of the market.

Interest in functional foods has also risen and many people are opting for naturally sourced foods that are enriched with this necessary nutritional supplementation and are incorporating them into their diet. APAC emerged as the largest regional market in 2021. Japan was the first country to approve such foods, back in the 1980s and other countries have been following suit. The plant-based products have also gained a lot of traction with more and more people turning to a vegan diet for a more holistic approach to health.

The functional foods and beverages product segment held the largest revenue share of over 55.0% in 2021. Food rich in supplements like minerals and vitamins, omega-3, and fiber-rich food is in high demand due to their benefits. The demand has grown significantly in recent years due to their long-term benefits. Apart from COVID, the use of these products for balancing nutritional imbalances, slowing down aging, and maintaining agility have been responsible for the growth of this segment. The sports nutrition product segment is expected to witness the fastest growth over the forecast period owing to the rising interest in fitness and overall health.

The powder formulation segment held the largest revenue share in 2021 due to the high product density in the market and this formulation is preferred over other forms of oral ingestion. The ease of use for all age groups has been key to driving this segment. The capsules segment is expected to grow at a significant CAGR from 2022 to 2030. Capsules come in multiple layers, in extended-release forms, which are meant for specific uses and are expected to witness significant growth in the future.

The brick-and-mortar sales channel captured the largest revenue share in 2021, despite being challenged by the online sales channel. With the COVID still in effect, people are preferring online purchases of products, but brick and mortar sales have not slowed down. It is expected to grow significantly. The e-commerce segment is expected to emerge as the fastest-growing sales channel over the forecast period due to key market player initiatives and the preference of people for purchasing.

The adult consumer group segment held the largest revenue share in 2021 owing to increased concerns related to health, higher susceptibility to chronic diseases, and overall awareness of the importance of a well-supplemented diet for complete health and well-being. The children segment is expected to witness significant growth over the forecast period because people are becoming more aware of proper nutritional requirements from a young age for better mental and physical development, thus fostering the growth of the market.

Asia Pacific was the highest-grossing region in 2021 in the market. The majority of the population in the region has become aware of the benefits of nutritional supplements and is keenly purchasing them, resulting in the growth of the market. In addition, countries like Japan and China are major exporters of nutritional supplements, accounting for billions per year. The growth in the market has been spurred due to COVID. Latin America is expected to register the fastest growth rate over the forecast period owing to the increasing chronic disease burden, rising awareness regarding the use of nutritional supplements, and the importance of maintaining a healthy lifestyle.

Despite lockdown being imposed across the globe, the market for nutritional supplements has grown multi-fold. People are increasingly becoming aware of the benefits of nutritional supplements and also moving towards leading a healthy lifestyle. Participation in sports or physical activity has increased over the years to combat obesity and has thus increased the number of sports and fitness enthusiasts. An increase in the consumption of sports nutrition products and general energy-boosting supplements has spurred the growth of the market.

Related Press Release@ Nutritional Supplements Market Report

Nutritional Supplements Market Report Highlights

  • By product, the functional foods and beverages segment held the largest revenue share in 2021 due to its increasing popularity. The sports nutrition segment is expected to emerge as the fastest-growing segment over the forecast period
  • Based on formulation, the powder segment had the largest market share in 2021 and is expected to witness significant growth in the coming years
  • The brick-and-mortar sales channel segment held the largest revenue share in 2021. The e-commerce sales channel is expected to register the fastest growth rate over the forecast period owing to the ease of distribution of this sales channel
  • The Asia Pacific region held the largest revenue share in 2021 owing to its large export capacity
 About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James

Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email:
sales@grandviewresearch.com
For More Information:
https://www.grandviewresearch.com

Europe Mobility Aids Market Size Worth $3.98 Billion By 2030

 

The Europe Mobility Aids Market size is expected to reach USD 3.98 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to grow at a significant CAGR of 3.2% in the forecast period. The high demand for home healthcare and an increase in the geriatric population requiring Long-term Care (LTC) are expected to propel the market growth during the forecast period. In addition, technical advancements in mobility aids are likely to boost product usage, resulting in market expansion. The introduction of new mobility support devices by key market players is anticipated to increase the number of products available in the market. This, in turn, will help facilitate the growth of the market.

Furthermore, the aging population in the U.K. has increased significantly in the past five decades. As per the statistics published by Age U.K., in 2020, around 18.65% of people in the country were aged 65 years or over. Moreover, around 4 million older citizens in the U.K. were estimated to suffer from long-term illnesses severely affecting their mobility. The increasing geriatric population is a key growth-driving factor for mobility aids. The pandemic has had an ongoing adverse impact on various industries across the globe. Stay-at-home mandates, transportation bans, and workforce crunch have resulted in the disruption of supply chains. Although the market was not significantly affected, the supply chain bottlenecks and restrictions on the product as well as patient movement caused a decrease in sales revenues.

Related Press Release@ Europe Mobility Aids Market Report

Europe Mobility Aids Market Report Highlights

  • The wheelchair segment spearheaded the market in 2021 due to an increasing number of disorders, such as spinal cord injuries, which require wheelchair support
  • The public segment was the largest in terms of revenue share due to the presence of established players offering a wide range of products
  • The offline distribution channel segment held a high revenue share in 2021. This is owing to a higher preference for the offline purchase of mobility aids
  • The rehabilitation care segment dominated the market in 2021 and will remain dominant throughout the forecast period

 About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James

Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email:
sales@grandviewresearch.com
For More Information:
https://www.grandviewresearch.com

Thailand Aesthetic Medicine Market by Dermaster Co., Ltd.; BSL Clinic; Thai Medical Vacation; Bumrungrad International Hospital

 

The Thailand Aesthetic Medicine Market size is anticipated to reach USD 3.45 billion by 2030, registering a CAGR of 9.7% during the forecast period, according to a new report by Grand View Research, Inc. The market is majorly driven by the increasing adoption of minimally invasive and non-invasive procedures coupled with growth in the population susceptible to signs of aging. Moreover, an increase in the incidence of road accidents is fuelling the demand for reconstructive surgeries, which is fuelling the growth of the market. According to the International Society of Aesthetic Plastic Surgery (ISAPS), among Asian countries, Thailand is among the top ten countries with the highest volume of invasive as well as non-invasive procedures. Cities, such as Bangkok and Phuket, are major cosmetic surgery hubs in the country, which have clusters of major aesthetic surgery hospitals and clinics.

According to a survey by the International Society of Aesthetic Plastic Surgery (ISAPS) in 2020, around 154,547 aesthetic procedures were performed in the country. Moreover, Thailand is a tourism-dependent economy where medical tourism is flourishing due to low treatment costs and high-quality post-treatment services. According to the Journal of Community Development Research, Thailand’s medical tourism industry expanded with a 10% revenue growth in 2019 from 2018. These factors might boost market growth. The advent of the COVID-19 pandemic has resulted in the cessation of medical tourism in Thailand during the first half of 2020. However, the market recovered significantly by 2021 and the procedural volume of aesthetic procedures both invasive and non-invasive was higher in 2020 as compared to 2019 indicating the rising demand for aesthetic treatments in the country.

Related Press Release@ Thailand Aesthetic Medicine Market Report

Thailand Aesthetic Medicine Market Report Highlights

  • The invasive procedure type segment accounted for the largest market share in 2021 due to the high number of medical tourists visiting the country for aesthetic surgical procedures
  • The non-invasive procedure type segment is expected to witness the fastest CAGR during the forecast period due to minimally invasive characteristics, immediate results, and low recovery period offered by these procedures
  • Botox injections held the largest market share in the non-invasive procedures segment in 2021 due to the availability of wide applications for Botox injections
  • On the basis of end-use, the clinics & aesthetic centers segment held the highest market share in 2021 owing to the fact that aesthetic clinics are increasingly offering customized treatments at cost-effective prices

 About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James

Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email:
sales@grandviewresearch.com
For More Information:
https://www.grandviewresearch.com

Thursday 23 February 2023

Rhinoplasty Market Worth $10.9 Billion By 2030 | CAGR: 8.9%

 

The global Rhinoplasty Market size is expected to reach USD 10.9 billion by 2030 at a CAGR of 8.9% during the forecast period, according to a new report by Grand View Research, Inc. Rhinoplasty is a type of surgery that changes the shape of the nose. It is one of the most popular types of facial plastic surgery. 

The increasing focus among people on physical appearance and technological advancements in the dermatology industry are some of the key factors anticipated to boost the demand for rhinoplasty during the forecast years. According to a report published by the International Society of Aesthetic Plastic Surgery (ISAPS), in 2018, 726,907 rhinoplasty surgeries were performed and were among the top 5 surgical procedures carried out at a global level. These stats suggest that there is a growing demand for rhinoplasty procedures and the rising awareness about cosmetic appeals is the most important factor contributing to the rhinoplasty surgery demand. 

The number of young people turning to cosmetic procedures to improve their looks is on the rise. Also, there is a rising trend in non-invasive, non-surgical rhinoplasty. The presence of skilled cosmetic and plastic surgeons and technological advancements such as 3D computer-assisted technologies are anticipated to further boost the market’s growth.  

The COVID-19 pandemic has significantly affected the market. Initially, due to lockdown and global restrictions being imposed in most countries, many surgeries were halted. The COVID-19 pandemic has caused a huge disruption in the supply chain of the overall medical industry. Initially, the outbreak has resulted in a decrease in the number of procedures performed each year, resulting in an overall decline in the market. 

As rhinoplasty involves surgery of the nose, cosmetic surgeons were at a huge risk of getting exposed to the coronavirus. However, recently, hospitals and specialty clinics have put pandemic protocols to be maintained for both safety of the staff and the patients. For instance, in the U.S., in one of the surgery centers, a patient getting tested for coronavirus 48 hours before any procedure or surgery, staff are mandated to use N95 masks, and so forth. In 2020, while aesthetic surgeries were being held virtually, certain emergency elective surgeries were being approved, that too after following strict protocols. 

Related Press Release@ Rhinoplasty Market Report

Rhinoplasty Market Report Highlights

  • Augmentation rhinoplasty emerged as the largest segment owing to its necessity for both functional and aesthetic indications
  • Open rhinoplasty accounted for a larger share in 2021 owing to its ability to alter nasal shape with precision and better facial appearance
  • Asia Pacific region is projected to be the fastest-growing region with a CAGR of 9.5% during the forecast period. Countries such as China and Japan are the hub of rhinoplasty surgeries in the region

 About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James

Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email:
sales@grandviewresearch.com
For More Information:
https://www.grandviewresearch.com

Wednesday 22 February 2023

Astaxanthin Market Worth $6.90 Billion By 2030 | CAGR: 17.2%

 

The global Astaxanthin Market size is expected to reach USD 6.90 billion by 2030, set to grow at a 17.2% CAGR from 2023 to 2030, according to a new report by Grand View Research, Inc. The increasing demand for nutraceuticals and growing applications of carotenoids in the animal feed industry & aquaculture are the major factors driving the market growth. Moreover, the rapidly aging population and the growing health awareness among consumers are likely to support market expansion.

The market is anticipated to witness growth opportunities owing to growth in the aquaculture and fishing sectors. For instance, Germany is expanding its fish production and according to the federal statistical office of Germany, the country produced around 18,300 tons of fish in 2021. The growth in the aquaculture sector across the globe is likely to propel the demand for astaxanthin as the pigment helps to boost the immunity of animals and enhance the pigmentation of aquatic animals, such as ornamental fish, and rainbow trout.

Moreover, the market growth is also fueled by various research & development activities to increase the adoption of astaxanthin. For instance, in December 2021, AstaReal and the University of Tsukuba announced a new patent and research showing that the astaxanthin molecules modulate the genes of the brain involved in neuron formation, memory, and learning. Moreover, in July 2020, Russian and German university scientists from SPbPU and TUHH announced a collaboration to enhance the production of astaxanthin for its antioxidant application.

Moreover, increasing studies related to the health benefits of natural astaxanthin are expected to increase the market uptake. For instance, in August 2022, a study published by the American Journal of Clinical Nutrition stated that krill oil can help manage stiffness, knee pain, and physical function in adults with osteoarthritis & knee pain between the ages of 40 and 65 years.

In addition, owing to the high demand for astaxanthin in international markets various leading players are strengthening their supply chain capabilities to make their products available. For instance, in July 2021, Atacama Bio Natural Products S.A. signed an exclusive distribution agreement with Guangzhou Carelife Food Additives Co., Ltd. to promote its distribution network in China. Moreover, in June 2022, Pharmactive Biotech Products partnership with Singapore-based Nutraconnect to introduce scientifically backed novel nutraceuticals into the Asia Pacific market.

Furthermore, supportive regulatory policies and increasing approval of products are driving the industry’s growth. For instance, in July 2021, NextFern Technologies received regulatory approval for its Astafern from Health Canada. Astafern is an innovative fermented astaxanthin antioxidant in form of gummies. In addition, the government has undertaken supportive registration requirements for carotenoid-based coloring agents and mixed feeds containing carotenoid-based coloring agents.

Related Press Release@ Astaxanthin Market Report

Astaxanthin Market Report Highlights

  • Based on product, the dried algae meal or biomass segment accounted for the largest share in 2022 due to the high usage as animal feed and lower cost of production
  • The aquaculture & animal feed segment was the highest revenue contributor in 2022. Whereas, the nutraceuticals segment is expected to exhibit the fastest CAGR during the projected period
  • The Asia Pacific region is expected to grow at the fastest rate over the forecast period due to the rising investments by market players and increasing research activities in the region

 About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James

Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email:
sales@grandviewresearch.com
For More Information:
https://www.grandviewresearch.com                                              

Friday 17 February 2023

Digital Pathology Market by Leica Biosystems (Danaher); Hamamatsu Photonics, Inc.; Koninklijke Philips N.V.; Olympus Corp.

The global Digital Pathology Market size is expected to reach USD 1.74 billion by 2030, registering a CAGR of 7.5% over the forecast period, according to a new report by Grand View Research, Inc. Increasing prevalence of chronic diseases triggers the demand for advanced diagnostics, which is expected to drive the market growth. Growing economic stability and awareness about the benefits of the use of computer-aided diagnostics is further contributing to the market growth. As with other laboratory medicine disciplines, the COVID-19 pandemic has had a surprising impact on digital pathology. The pandemic has shortened all but the most serious surgeries and cancer treatments.

Thus, histology laboratories are involved in the most difficult task of collecting & analyzing tissue samples for the procedure. There was also a workforce shortage with many pathologists staying out of the laboratory due to physical distancing measures. Thus, altered rules allowed greater usage of digital pathology along with the reading of the test results from remote settings, which supported the overall market growth. During the pandemic, pathologists had to continue working from home. This formed an unprecedented necessity for home workplaces and protect clinical informatics solutions permitting clinicians to read images remotely and allowing real-time virtual alliance between their multi-disciplinary care teams.

Pre-COVID-19, pathology laboratories that digitized their workflows across diverse sites reported an average productivity gain of 21%. The COVID-19 pandemic augmented the implementation of digital pathology for several reasons, such as changes in regulatory requirements and governance. Technological advancements, such as digital imaging, computerization, robotic light microscopy, and multiple fiber optic communications are some of the key factors driving the adoption of digital pathology. In addition, the introduction of cloud-based technology enabling the storage of digital slides coupled with secure access to pathologists is expected to serve as a potential growth driver for the market.

Moreover, the use of Artificial Intelligence (AI)has proven to be more effective than previous techniques used in identifying and evaluating pathological characteristics in samples. The implementation of AI helps accelerate & strengthen diagnosis and makes the process of drug discovery more successful and cost-efficient. Moreover, by using data to verify diagnoses made by pathologists, AI helps minimize error rates, as it can alert them if the algorithms measuring their conclusion are not in accordance with what is expected. This shows the potential demand for AI-based pathology solutions in the coming years.

Digital pathology has an important role in companion diagnostics and drug development pipelines, including molecular biology, biobanking, molecular tissue profiling, and tissue microarray analysis. Increasing demand for high-quality tissue samples in tissue-based biomarker research is expected to propel the adoption of the technology over the forecast period. The market is expected to witness intense competition in near future owing to the rising adoption of rigorous strategies by key players to sustain competition. For instance, whole slide imaging system manufacturers focus on obtaining premarket approval for diagnostic digital systems to capture a greater revenue share.

Related Press Release@ Digital Pathology Market Report

Digital Pathology Market Report Highlights

  • The device segment held the dominant market share in 2021 owing to the increased use in academic research on account of various benefits, such as cost-effectiveness and rapid results
  • The rising implementation of slide management systems in stratified medicine and tissue-based biomarker research is one of the key contributing factors for the dominance of this technology
  • The software segment is expected to witness the fastest CAGR over the forecast years as the product assists in faster diagnosis and synchronization of patient data, where healthcare professionals can remotely access this information
  • The disease diagnosis segment is expected to witness the fastest CAGR over the forecast period due to the increasing prevalence of cancer and demand for noble diagnosis techniques
  • The availability of unified platforms for workflows in pathology is anticipated to boost the usage of computer-aided imaging technology in academic research, which is anticipated to boost the segment growth
  • The market is expected to remain innovation-led, with frequent acquisitions and strategic alliances
  • In October 2021, Philips introduced IntelliSite. It features a scalable group of software tools and proficiencies that help streamline workflows, improve diagnostic confidence, enable teamwork, integrate AI, and enhance the efficiency of path labs

 About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James

Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email:
sales@grandviewresearch.com
For More Information:
https://www.grandviewresearch.com

Digital Pathology Market Size To Reach $1.73 Billion By 2030

The global  Digital Pathology Market  size is expected to reach USD 1.73 billion by 2030, registering a CAGR of 8.0% from 2024 to 2030, acco...